Delivering new insights to drive personalized trials

腎臓病学

Collaborate with a board-certified nephrologist (who is also in academia), to ensure successful trial design and execution

Engage Fortrea’s regulatory strategy and operational experts for data-driven planning

Leverage relationships with nephrology sites and trial stakeholders (such as Dialysis Organizations and Kidney Patient Advocacy Groups) to deliver timely diversity-focused recruitment

Experience matters when choosing a partner

お問い合わせはこちら

過去 5 年間の実績

178

Nephrology Studies

5,000+

施設

23,000+

患者様

Dialysis and End Stage Kidney Disease (ESKD)

Glomerular Disease

Chronic Kidney Disease (CKD) and its complications

Pediatric CDK and ESKD

Renal Impairment Studies

Fortrea の最新情報

We’re sharing our latest news, events, and publications

ウェビナー

参加登録はこちら

記事

Recent advances in the use of surrogate endpoints in kidney diseases

記事を読む

ウェビナー

Dr. Barbara Gillespie co-moderates the Kidney Health Initiative webinar (58 minutes)

View the recording

Why choose Fortrea for your next Nephrology trial?

Hear and apply our lessons learned across the different types of nephrology studies to understand the nuances of sites and recipe for successful trial execution in dialysis vs. rare kidney disease (e.g., Glomerular Disease) vs. common CKD (e.g., Diabetic Kidney Disease) patients
Benefit from our focused training specific to the needs of each type of nephrology study to address issues such as proper 24-hour urine collections, renal biomarker development, PRO collection and central lab monitoring
Harness the dedicated and overlapping expertise of our partners in Clinical Pharmacology Solutions and our Rare and Pediatric Disease colleagues

Renal Impairment Studies 希少疾患

チームメンバーのご紹介

Barbara S. Gillespie 医師、医学修士、米国腎臓学会特別研究員（FASN） Vice President & Therapeutic Strategy Leader

チームのご紹介

Your agile partner for comprehensive nephrology clinical trials

We bring extensive depth of expertise to nephrology therapeutic development. Once your trial is underway, you can rely on Fortrea's clinical trial management team to provide close communication and collaboration. We use a highly flexible clinical platform for electronic patient-reported outcomes to provide high-quality data that enables you to stay connected to the progress of your program.

Fortrea はフェーズ I から IV までの治験管理、臨床薬理、患者様アクセスソリューション、その他業務を実現するサービスの総合的なプロバイダーとして、バイオ医薬品、医療機器、診断の各分野の新興企業や大手企業と提携し、革新的なヘルスケアを世界中に促進するべく取り組んでいます。